Top 10 Pharmaceutical Companies in China

Robert Gultig

21 November 2025

Top 10 Pharmaceutical Companies in China

User avatar placeholder
Written by Robert Gultig

21 November 2025

Introduction:

The pharmaceutical industry in China has been experiencing rapid growth in recent years, driven by increasing demand for healthcare products and services. According to recent statistics, the pharmaceutical market in China is estimated to be worth over $160 billion, making it one of the largest in the world. This report will highlight the top 10 pharmaceutical companies in China, showcasing their production volumes, market shares, and overall performance in the industry.

Top 10 Pharmaceutical Companies in China:

1. Sinopharm Group Co., Ltd.
Sinopharm Group is the largest pharmaceutical company in China, with a market share of over 10%. The company specializes in the production of a wide range of pharmaceutical products, including traditional Chinese medicines and western medicines.

2. Shanghai Pharmaceuticals Holding Co., Ltd.
Shanghai Pharmaceuticals Holding is a leading pharmaceutical company in China, with a strong presence in both domestic and international markets. The company’s production volume exceeds 100,000 tons annually, making it a key player in the industry.

3. Jiangsu Hengrui Medicine Co., Ltd.
Jiangsu Hengrui Medicine is known for its innovative research and development capabilities, with a focus on oncology, cardiovascular, and metabolic diseases. The company has a market share of over 5% in China.

4. China Meheco Co., Ltd.
China Meheco is a state-owned pharmaceutical company that specializes in the distribution and marketing of pharmaceutical products. The company’s export value exceeds $1 billion annually, making it a key player in the international market.

5. Fosun Pharma
Fosun Pharma is a leading pharmaceutical company in China, with a focus on research and development of innovative drugs. The company’s market share in China is over 4%, and it has a strong presence in global markets.

6. CSPC Pharmaceutical Group Limited
CSPC Pharmaceutical Group is a leading manufacturer of pharmaceutical products in China, with a focus on cardiovascular, anti-infective, and metabolic diseases. The company’s production volume exceeds 50,000 tons annually.

7. Harbin Pharmaceutical Group
Harbin Pharmaceutical Group is a state-owned pharmaceutical company that specializes in the production of traditional Chinese medicines. The company’s market share in China is over 3%, and it has a strong presence in the domestic market.

8. Sino Biopharmaceutical Limited
Sino Biopharmaceutical is a leading biopharmaceutical company in China, with a focus on research and development of innovative drugs. The company’s market share in China exceeds 4%, and it has a strong presence in international markets.

9. 3SBio Inc.
3SBio Inc. is a biopharmaceutical company that specializes in the development of innovative therapies for autoimmune diseases and cancer. The company’s market share in China is over 2%, and it has a strong presence in global markets.

10. Zhejiang Hisun Pharmaceutical Co., Ltd.
Zhejiang Hisun Pharmaceutical is a leading pharmaceutical company in China, with a focus on research and development of generic drugs. The company’s production volume exceeds 70,000 tons annually, making it a key player in the industry.

Insights:

The pharmaceutical industry in China is expected to continue its rapid growth in the coming years, driven by increasing demand for healthcare products and services. According to forecasts, the market size of the pharmaceutical industry in China is expected to exceed $200 billion by 2025, making it one of the largest in the world. As the Chinese government continues to invest in healthcare infrastructure and innovation, the top pharmaceutical companies in China are well-positioned to capitalize on these opportunities and drive further growth in the industry.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →